The Joint DIA FIP European Workshop Biorelevant Performance Testing of Orally Administered Dosage Forms 2014 is dedicated to
- Biorelevant in vitro Performance Tests
- Challenges in Simulating the Changing GI Environment for the Evaluation of Dosage Form Performance
- Evaluation of Supersaturating Drug Delivery Systems
- Evaluation of Lipid Dosage Forms
- Gastrointestinal Physiology and in vitro Simulation
- Luminal Hydrodynamics and in vitro Simulation
- Luminal Composition and in vitro Simulation
- Oral Biopharmaceutics Tools: A European academic-industy consortium
- Biorelevant in vitro Performance Tests: Definitions and current issues
- Looking at the Regulators
- Biorelevance versus Quality Control: Separate or bridge?
- PBPK Modeling of Oral Drug Absorption
- PBPK Modeling of Oral Drug Absorption Using SimSyp
- PBPK Modeling of Oral Drug Absorption Using PK-Sim
- PBPK Modeling of Oral Drug Absorption Using GastroPlus
Who should Attend
Scientists from industry, academia and regulatory agencies, including graduate students with a primary interest in development of orally administered drug products.
